[	0	1	O
Study	1	6	O
on	7	9	O
the	10	13	O
expression	14	24	O
of	25	27	O
angiogenesis	28	40	O
and	41	44	O
spontaneous	45	56	O
apoptosis	57	66	O
and	67	70	O
their	71	76	O
relevance	77	86	O
in	87	89	O
laryngeal	90	99	B-Pathological_formation
squamous	100	108	I-Pathological_formation
cell	109	113	I-Pathological_formation
carcinoma	114	123	I-Pathological_formation
]	123	124	O

OBJECTIVE	126	135	O
:	135	136	O
To	137	139	O
investigate	140	151	O
the	152	155	O
relationship	156	168	O
among	169	174	O
angiogenesis	175	187	O
,	187	188	O
spontaneous	189	200	O
apoptosis	201	210	O
and	211	214	O
clinicopathological	215	234	O
parameters	235	245	O
in	246	248	O
laryngeal	249	258	B-Pathological_formation
squamous	259	267	I-Pathological_formation
cell	268	272	I-Pathological_formation
carcinoma	273	282	I-Pathological_formation
(	283	284	O
LSCC	284	288	B-Pathological_formation
)	288	289	O
.	289	290	O

METHOD	291	297	O
:	297	298	O
The	299	302	O
intratumor	303	313	O
microvessel	314	325	B-Tissue
density	326	333	O
(	334	335	O
IMVD	335	339	O
)	339	340	O
,	340	341	O
apoptotic	342	351	O
index	352	357	O
(	358	359	O
AI	359	361	O
)	361	362	O
and	363	366	O
vascular	367	375	B-Gene_or_gene_product
endothelial	376	387	I-Gene_or_gene_product
growth	388	394	I-Gene_or_gene_product
factor	395	401	I-Gene_or_gene_product
(	402	403	O
VEGF	403	407	B-Gene_or_gene_product
)	407	408	O
expression	409	419	O
were	420	424	O
detected	425	433	O
by	434	436	O
immunohistochemistry	437	457	O
SABC	458	462	O
and	463	466	O
terminal	467	475	O
uridine	476	483	O
deoxynucleotidyl	484	500	O
transferase	501	512	O
mediated	513	521	O
nick	522	526	O
end	527	530	O
labeling	531	539	O
(	539	540	O
TUNEL	540	545	O
)	545	546	O
methods	547	554	O
in34	555	559	O
LSCC	560	564	B-Pathological_formation
patients	565	573	B-Organism
.	573	574	O

RESULT	575	581	O
:	581	582	O
The	583	586	O
average	587	594	O
IMVD	595	599	O
was	600	603	O
(	604	605	O
21	605	607	O
.	607	608	O
50	608	610	O
+	611	612	O
/	612	613	O
-	613	614	O
8	615	616	O
.	616	617	O
87	617	619	O
)	619	620	O
,	620	621	O
and	622	625	O
median	626	632	O
of	633	635	O
AI	636	638	O
was	639	642	O
1	643	644	O
.	644	645	O
15	645	647	O
%	647	648	O
.	648	649	O

The	650	653	O
average	654	661	O
IMVD	662	666	O
in	667	669	O
positive	670	678	O
and	679	682	O
negative	683	691	O
cervical	692	700	B-Pathological_formation
lymphatic	701	710	I-Pathological_formation
metastasis	711	721	I-Pathological_formation
was	722	725	O
(	726	727	O
26	727	729	O
.	729	730	O
33	730	732	O
+	733	734	O
/	734	735	O
-	735	736	O
9	737	738	O
.	738	739	O
70	739	741	O
)	741	742	O
and	743	746	O
(	747	748	O
17	748	750	O
.	750	751	O
68	751	753	O
+	754	755	O
/	755	756	O
-	756	757	O
6	758	759	O
.	759	760	O
06	760	762	O
)	762	763	O
respectively	764	776	O
,	776	777	O
and	778	781	O
the	782	785	O
IMVD	786	790	O
with	791	795	O
positive	796	804	O
lymphatic	805	814	B-Pathological_formation
metastasis	815	825	I-Pathological_formation
tumors	826	832	I-Pathological_formation
was	833	836	O
statistical	837	848	O
significantly	849	862	O
higher	863	869	O
than	870	874	O
those	875	880	O
with	881	885	O
negative	886	894	O
cervical	895	903	B-Pathological_formation
lymphatic	904	913	I-Pathological_formation
metastasis	914	924	I-Pathological_formation
tumors	925	931	I-Pathological_formation
(	932	933	O
P	933	934	O
less	936	940	O
than	941	945	O
0	947	948	O
.	948	949	O
01	949	951	O
)	951	952	O
.	952	953	O

The	954	957	O
average	958	965	O
IMVD	966	970	O
had	971	974	O
statistical	975	986	O
difference	987	997	O
in	998	1000	O
histological	1001	1013	O
grading	1014	1021	O
(	1022	1023	O
P	1023	1024	O
less	1026	1030	O
than	1031	1035	O
0	1037	1038	O
.	1038	1039	O
01	1039	1041	O
)	1041	1042	O
,	1042	1043	O
and	1044	1047	O
analysis	1048	1056	O
by	1057	1059	O
one	1060	1063	O
to	1064	1066	O
one	1067	1070	O
,	1070	1071	O
the	1072	1075	O
average	1076	1083	O
IMVD	1084	1088	O
had	1089	1092	O
statistical	1093	1104	O
difference	1105	1115	O
between	1116	1123	O
high	1124	1128	O
and	1129	1132	O
median	1133	1139	O
grading	1140	1147	O
.	1147	1148	O

Expression	1149	1159	O
of	1160	1162	O
VEGF	1163	1167	B-Gene_or_gene_product
had	1168	1171	O
a	1172	1173	O
significantly	1174	1187	O
positive	1188	1196	O
correlation	1197	1208	O
with	1209	1213	O
IMVD	1214	1218	O
(	1219	1220	O
r	1220	1221	O
=	1222	1223	O
0	1224	1225	O
.	1225	1226	O
51	1226	1228	O
,	1228	1229	O
P	1230	1231	O
less	1233	1237	O
than	1238	1242	O
0	1244	1245	O
.	1245	1246	O
01	1246	1248	O
)	1248	1249	O
.	1249	1250	O

Statistical	1251	1262	O
analysis	1263	1271	O
revealed	1272	1280	O
a	1281	1282	O
significantly	1283	1296	O
inverse	1297	1304	O
correlation	1305	1316	O
between	1317	1324	O
AI	1325	1327	O
and	1328	1331	O
IMVD	1332	1336	O
(	1337	1338	O
r	1338	1339	O
=	1340	1341	O
-	1342	1343	O
0	1343	1344	O
.	1344	1345	O
53	1345	1347	O
,	1347	1348	O
P	1349	1350	O
less	1352	1356	O
than	1357	1361	O
0	1363	1364	O
.	1364	1365	O
01	1365	1367	O
)	1367	1368	O
.	1368	1369	O

We	1370	1372	O
failed	1373	1379	O
to	1380	1382	O
find	1383	1387	O
the	1388	1391	O
statistical	1392	1403	O
difference	1404	1414	O
between	1415	1422	O
IMVD	1423	1427	O
and	1428	1431	O
tumor	1432	1437	B-Pathological_formation
T	1438	1439	O
-	1439	1440	O
stage	1440	1445	O
in	1446	1448	O
LSCC	1449	1453	B-Pathological_formation
.	1453	1454	O

CONCLUSION	1455	1465	O
:	1465	1466	O
IMVD	1467	1471	O
may	1472	1475	O
be	1476	1478	O
an	1479	1481	O
important	1482	1491	O
indicator	1492	1501	O
to	1502	1504	O
predict	1505	1512	O
cervical	1513	1521	B-Pathological_formation
lymphatic	1522	1531	I-Pathological_formation
metastasis	1532	1542	I-Pathological_formation
in	1543	1545	O
LSCC	1546	1550	B-Pathological_formation
.	1550	1551	O

VEGF	1552	1556	B-Gene_or_gene_product
might	1557	1562	O
be	1563	1565	O
an	1566	1568	O
important	1569	1578	O
angiogenic	1579	1589	O
factor	1590	1596	O
,	1596	1597	O
and	1598	1601	O
could	1602	1607	O
promote	1608	1615	O
tumor	1616	1621	B-Pathological_formation
angiogenesis	1622	1634	O
in	1635	1637	O
LSCC	1638	1642	B-Pathological_formation
.	1642	1643	O

Tumor	1644	1649	B-Pathological_formation
angiogenesis	1650	1662	O
might	1663	1668	O
contribute	1669	1679	O
to	1680	1682	O
tumor	1683	1688	B-Pathological_formation
malignant	1689	1698	O
progression	1699	1710	O
by	1711	1713	O
inhibiting	1714	1724	O
spontaneous	1725	1736	O
apoptosis	1737	1746	O
in	1747	1749	O
LSCC	1750	1754	B-Pathological_formation
.	1754	1755	O

